Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Anti-tumor immune response in ovarian cancer: clinical implications, prognostic significance and potential for novel treatment strategies — Nikos G. Gavalas (2009) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Anti-tumor immune response in ovarian cancer: clinical implications, prognostic significance and potential for novel treatment strategies
Shared by
Meletios A Dimopoulos
Anti-tumor immune response in ovarian cancer: clinical implications, prognostic significance and potential for novel treatment strategies
Article
2009
en
Authors
NG
Nikos G. Gavalas
Meletios A Dimopoulos
AB
Aristotelis Bamias
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2011
Anti-tumor immune response in ovarian cancer: clinical implications, prognostic significance and potential for novel treatment strategies
Nikos G. Gavalas
,
Meletios A Dimopoulos
,
Aristotelis Bamias
Article
2011
Anti-tumor immune response in ovarian cancer: clinical implications, prognostic significance and potential for novel treatment strategies
Nikos G. Gavalas
,
Meletios A Dimopoulos
,
Aristotelis Bamias
Article
2010
Immune Response in Ovarian Cancer: How Is the Immune SystemInvolved in Prognosis and Therapy: Potential for Treatment Utilization
Nikos G. Gavalas
,
Alexandra Karadimou
,
Meletios A Dimopoulos
,
Aristotelis Bamias
Article
2023
Pyroptosis and the tumor immune microenvironment: A new battlefield in ovarian cancer treatment
Aihong Wang
,
Yin Wang
,
Chenxiang Du
,
Huilun Yang
,
Zhengping Wang
,
Canhui Jin
,
Michael R Hamblin
Article
2020
Factors Affecting Photodynamic Therapy and Anti-Tumor Immune Response
Michael R Hamblin
,
Heidi Abrahamse
Discussion(0)
No comments yet. Be the first to comment.